Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research Study

PURPOSE: To determine the usability of the ergonomically designed certolizumab pegol pre-filled pen (CZP PFP) in Australian patients with active ankylosing spondylitis, active psoriatic arthritis or moderate-to-severe rheumatoid arthritis. PATIENTS AND METHODS: CZP-naive patients were recruited from...

Descripción completa

Detalles Bibliográficos
Autores principales: Aw, Juan, Griffiths, Hedley, Zochling, Jane, Lanzafame, Alfred, Jordan, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254605/
https://www.ncbi.nlm.nih.gov/pubmed/34234420
http://dx.doi.org/10.2147/PPA.S310086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254605/
https://www.ncbi.nlm.nih.gov/pubmed/34234420
http://dx.doi.org/10.2147/PPA.S310086

Ejemplares similares